Table 1 Overview of studies and results.

From: Systematic review of primary and booster COVID-19 sera neutralizing ability against SARS-CoV-2 omicron variant

Primary vaccination series

   

No. Obs

No. of Sera

Fold decrease (Omicron)

Median % responders (Omicron)

Median GMT (Parent)

Type of vaccination

Platform

Vaccine

Q1

Median

Q3

Homologous

Inactivated

BBIBP-CorV

4

325

1.9

7.2

11.2

23

67.4

CoronaVac

4

135

5.4

9.5

14.5

0

32.5

mRNA

mRNA-1273

14

275

15.8

25.5

42.6

94

1039

Comirnaty

33

777

18.9

23.1

34.7

38

347.9

Vector

Vaxzevria

6

131

13.3

17.5

25

12

133

Sputnik V

2

26

7.6

7.6

7.6

44.5

66.5

Ad26.COV2.S

7

128

3.0

6.2

10.7

8.5

96

Heterologous

Vector + mRNA

Vaxzevria + mRNA-1273

1

11

19.5

19.5

19.5

82

671.4

Vaxzevria + Comirnaty

1

15

24.5

24.5

24.5

80

661.6

Total

72

1823

     

Booster

Homologous

Inactivated

BBIBP-CorV (3 doses)

4

408

8.6

11.4

15.8

78

361.8

CoronaVac (3 doses)

2

70

9.7

13.1

16.5

72.5

164.3

mRNA

mRNA-1273 (3 doses)

7

74

4.2

5.5

15

100

3942

Comirnaty (3 doses)

19

438

4

7.4

13.1

100

1749.5

Protein subunit

Anhui ZL (3 doses)

3

44

3

9.4

10.6

56

329

Vector

Sputnik V + Sputnik Light

1

6

7.1

7.1

7.1

100

359.2

Ad26.COV2.S (2 doses)

1

20

2.8

2.8

2.8

100

127.6

Heterologous

Inactivated + Protein subunit

BBIBP-CorV + Anhui ZL

2

20

11.8

13.4

14.9

90

1527.5

Inactivated + mRNA

CoronaVac + Comirnaty

2

85

6.1

6.7

7.3

100

320

mRNA + mRNA

mRNA-1273 + Comirnaty

1

4

13.1

13.1

13.1

75

984.3

Comirnaty + mRNA-1273

1

4

9.8

9.8

9.8

100

1378.6

mRNA + Vector

Comirnaty + Ad26.COV2.S

2

61

2.9

3.6

4.2

100

2456.3

Vector + mRNA

Ad26.COV2.S + Comirnaty

1

20

-

-

-

100

1044.9

Vector + Protein subunit

Vaxzevria + MVC-COV1901

1

73

6.6

6.6

6.6

N/R

404.8

Total

47

1327

     
  1. Results for each vaccine regimen (primary series and booster), with median fold change against Omicron, IQR, and median GMT against the parent strain (which was chosen to be similar to the vaccine-seed strain). Results could not be extracted; N/R Not Reported. References 4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52,53 were used to collect the source data used in the analysis, which can be found in the Source Data file.